Digitalis Purpurea Pellet
Product Images NDC 15631-0167

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Digitalis Purpurea (NDC 15631-0167). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rxhomeo Private Limited D.b.a. Rxhomeo, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Pellets Fda 15631 0167

Label Pellets Fda 15631 0167
This is a description of a homeopathic medicine--DIGITALIS PURPUREA 6X EikE. The product contains active and inactive ingredients, and is suggested for temporary relief of swollen legs. The dosage recommendations are provided for adults and children over two years old. The manufacturer's address, production and expiration dates, as well as the product name and content are listed.*
FDA Label Image

Mini Labels Pellets Fda15631 0167

Mini Labels Pellets Fda15631 0167
This text provides information on the ingredients and uses of a medicine. The active ingredient is not mentioned but there is a reference to Digitalis Purpurea 6X. The medicine is intended for temporary relief of swollen legs. The dosage instructions suggest taking 4 or pellets by mouth, three times daily for adults and half the adult dose for children over 2 years of age. The medicine comes in pellet form and is packaged with a mini label and blister pack for select pack sizes. The NDC number and manufacturing and expiration dates are also provided.*
FDA Label Image

Rxhomeo Secondary Packing Blister Pack

FDA Label Image

Rxhomeo Secondary Packing Carton Pack

Rxhomeo   Secondary Packing   Carton Pack
This is a description of a lactose-free, single homeopathic remedy manufactured by Rihomeo Private Limited in Hyderabad, India. The product is distributed by Rehomeo Inc. in Texas, USA. The remedy is manufactured according to the Homoeopathic Pharmacopoeia of the United States (HPUS). The warning advises not to use the product for serious conditions, and if symptoms do not improve in four days or worsen, then to discontinue use and seek assistance from a health professional. It further cautions pregnant or nursing mothers not to use the product without consulting a professional. This remedy is for oral consumption and to be stored in a cool and dark place. The label inside of the product provides dosage instructions. The text also mentions packing information, but it is not clear whether this information is relevant to the description of the product.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.